chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I started taking hydroxychloroquine in October of 2020. I was good and no longer sleepy, but by March 15th, 2021 I was mentally confused, exhausted, and I couldn't stand for no more than 20 minutes. It has continued up until now. I stopped taking that medicine at the end of July 2021 because it felt like my head was going to explode.
Dizzy; Nausea; she broke out with what felt like a million bugs on her head and face, states it is burning and itching/burning and itching on face and head during hair appointment; felt bad/did not feel right all day; she broke out with what felt like a million bugs on her head and face, states it is burning and itching/burning and itching on face and head during hair appointment; there is a lot of paranoia; This is a spontaneous report received from a contactable consumer (who is also the patient). A 31-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: EK9231), via an unspecified route of administration, on 28Dec2020, at single dose, for COVID-19 immunization. There were no medical history and concomitant medications. The patient stated she got the first dose of the Pfizer Covid vaccine on Monday, 28Dec2020. She mentioned that she read the list of side effects and all the print outs and stated her events were not on there. She wanted to make sure and stated maybe it was not even from the vaccine. She reported she just came from the hair dresser, had hair colored before many times, but today (30Dec2020), when she put the dye on her hair, she broke out with what felt like a million bugs on her head and face, stated it is burning and itching, maybe it is her imagination. She knows there is a lot of paranoia. She reported that she has had hair colored before and this has never happened, it occurred during hair coloring treatment. She also mentioned that on 30Dec2020 (also reported as "yesterday", pending clarification), she felt dizzy and nauseous; on 29Dec2020 (reported as "yesterday"), she felt bad and did not feel right all day, but says she knows those were listed symptoms. The outcome of the events dizziness, nausea, burning sensation and pruritus was recovering; the outcome of events paranoia and feeling abnormal was unknown.
Within a few hours  after  2nd dose  .hives appeared on throat and chest.itching accompanied the effect
Patient received Pfizer (2nd dose) instead of Moderna (2nd dose)   Previous dose was not available to nursing home and miscommunicated from family.
On 4/8/2021 I developed a headache after receiving the Johnson and Johnson vaccine. I took the next few days easy, and laid in bed for the majority of the weekend. On 4/10/2021 I left my residence to get dinner and noticed I was short of breath just walking from the building to my car. The shortness of breath worsened over the next few days. On 4/13/2021 I called a clinic and told them I had been short of breath and they directed me to the ER. I arrived to the ER around 2:30 in the afternoon. They ordered a chest x-ray and ran a test to determine if I could have a blood clot. The test came back with results indicating I could have a blood clot, so they did a chest CT and an MRI. The chest CT showed a blood clot in my left pulmonary artery. They prescribed a blood thinner, told me to stop taking oral birth control, and discharged me.
On 1/1/19 I felt warm, injection site was hot and sore. Stomach upset, headache. On 1/2/19 at 10AM I had a second seizure for approximately 1-1 1/2 min. I have been controlled for 9 1/2 mo. This is the first two seizures I had and only since the shot. No adverse effect on first shot.
at the injection site it is feeling really itchy; A spontaneous report was received from a reporter like consumer concerning a  unknown Years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events vaccination site itching and it hurts once in a while.  The patient's medical history was not provided. No relevant concomitant medications were reported.    On 27-JAN-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 29-JAN-2021, The patient experienced the events vaccination site itching and it hurts in a while.  No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not reported.   At the time of this report, the outcome of the events vaccination site itching and it hurts in a while  was unknown.  The reporter assessed the events vaccination site itching and it hurts in a while as related to study drug.
2012-13 Flu vaccination at 130pm on 10/2/12 - OK until approximately 530-6pm, felt weak/shaky, pain to lower back, SOB, hot/chills, next day still felt weak, chills decreased - now feels better (10/4/12).
Fever beginning on sixth day after vaccine and lasting for five days.  Treated with tylenol and motrin.
Patient was waiting in post-vaccine area and started to develop chest tightness and tingling in right arm. She reported no shortness of breath. She was visibally distraught and uncomfortable with her symptoms so I moved her to the vaccine room for privacy and called 911 for an ambulance. She continued to complain of chest tightness and the tingling is now in both arms and spreading to her legs. She also mentioned numbness around her mouth. The 911 dispatcher kept me on the phone until the paramedics arrived. The 911 dispatcher instructed me to give the patient #4 81mg Aspirin. The paramedics arrived and checked her vitals (heart rate, pulsox, EKG, blood pressure) and all results were normal. The patient started to feel better and did not leave with the paramedics. The paramedics recommended follow-up with an ER or Urgent Care for further monitoring. The paramedics discussed the reaction being either a slow allergic reaction to the vaccine or an anxiety attack.
A company representative reported that a male child received a 3rd dose of Prevnar vaccine on 3/5/02. Medical History included developmental delay. Two days post-immunization, the child experienced an episode of 6th nerve paralysis. He was seen at an eye institute and had surgery. He wore glasses and the symptoms abated. No further information was available at the date of this report. Additional information received by telephone message on 1/30/03, from the company representative, revealed that it was the child's mother who thought that the 6th nerve paralysis began after her child received a vaccine that began with a P, possibly Prevnar. The physician did not think the paralysis was vaccine related, but perhaps due to a virus. The physician, his staff and the mother of the child do no wish to pursue this speculation, nor be called on or contacted.
1st 2nd and 3rd Vision headache episode after first dose; Sore arm after first vaccine dose; I have been having off and on, uncharacteristically strange dreams; Causes anxiety; Wakes me up in the middle of the night / keeps me up; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ABNORMAL DREAMS (I have been having off and on, uncharacteristically strange dreams), ANXIETY (Causes anxiety), INSOMNIA (Wakes me up in the middle of the night / keeps me up), HEADACHE (1st 2nd and 3rd Vision headache episode after first dose) and VACCINATION SITE PAIN (Sore arm after first vaccine dose) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043L20A and 001A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and VITAMINS NOS for an unknown indication.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Jan-2021, the patient experienced ABNORMAL DREAMS (I have been having off and on, uncharacteristically strange dreams), ANXIETY (Causes anxiety) and INSOMNIA (Wakes me up in the middle of the night / keeps me up). On an unknown date, the patient experienced HEADACHE (1st 2nd and 3rd Vision headache episode after first dose) and VACCINATION SITE PAIN (Sore arm after first vaccine dose). At the time of the report, ABNORMAL DREAMS (I have been having off and on, uncharacteristically strange dreams), ANXIETY (Causes anxiety), INSOMNIA (Wakes me up in the middle of the night / keeps me up), HEADACHE (1st 2nd and 3rd Vision headache episode after last dose) and VACCINATION SITE PAIN (Sore arm after first vaccine dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Magnetic resonance imaging: normal (normal) normal.         Patient started with sore arm, 3 vision headache episodes. These headache episodes occurred 3 times over the 2 weeks period after the first dose. She had second vaccine dose on 27Feb2021 on her left arm, and for about 4.5 weeks had no headache but then had 4 episodes of vision headaches. Patient had 7 total headache episodes, then she went to see her Doctor. Patient had 7 total headache episodes, then she went to see her Doctor, and brain MRI was performed but nothing was found to be related to this situation.  Treatment information was not provided.   This case was linked to MOD-2021-093357  (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Follow-up received on 21-APR-2021.Added new AE(Sore arm, 1st,2nd,3rd Vision headache episode after first dose) and dose 2.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Patient was vaccinated on 4/3/21 and 4/24/21, so was fully vaccinated when testing positive for COVID-19 on 9/27/21.
Patient presented to the office for administration of Moderna Bilvalent Vaccine. However when documenting the administration of the vaccine 3 hours later, it was noted that the incorrect vaccine was pulled and administered. The patient received a monovalent booster dose instead of the bivalent booster dose. Regulatory authority was contacted and after discussing with the regulatory authority, the patient was notified of the error and that they will be eligible for a bivalent booster dose in 2 months. The patient remained in office for 15 minutes post vaccination and did not experience any adverse reactions during that time.
On 8-9-2010 client was given H1N1 0.1ml. intradermally instead of TB -  PPD in the left inner forearm. 8-11-2010 Left forearm observed - 3 cm area of redness. No complaints of discomfort. Recommended antihistamine. 8-13-10 Facial redness only.
tingle or feeling on my neck to the base of the scull; This is a spontaneous report from a contactable consumer (patient). A 77-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 2 via an unspecified route of administration, administered in arm left on 25Feb2021 at 16:45 (Batch/Lot Number: EN6200) as dose 2, single for COVID-19 immunisation. The patient medical history and concomitant medications were reported as none. Historical vaccine information included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: EN6200) 1st dose on 03Feb2021 at 11:00 (at the age of 77-year-old), administered in left arm for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Patient had not taken any other medicine in last two weeks. The patient did not have COVID prior vaccination and had no known allergies. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced tingle or feeling on her neck to the base of the scull on an unspecified date. This is felt on the same side of the neck that the shot was administered. COVID Pfizer vaccine was administered on 03Feb201 and was still present as of 02Mar2021. Patient did not receive any treatment. The clinical outcome of the event was not resolved.  No follow-up attempts are possible. No further information is expected.
Became ill and required hospitalization with COVID-19 after receiving 2 COVID vaccines and a booster.
Rash on trunk and face appeared 5/25/00 - presented to hospital out patient dept 5/26. No fever, coryza, cough or conjunctivitis. Pt seen by PHN 5/29/01 no rash apparent.
Persitant redness, itching and swelling of the upper arm for a week followed by a general feeling of tiredness, headaches and general achiness lasting for several weeks
pt recv vax;exp fever of 104;exp lack of appetite;small red spots on trunks,arms,legs,face;severe d & v;
Patient's 1st dose was two years ago; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose was received 2 years ago from the date of reporting).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: Age at vaccination was not applicable for this report. The pharmacist asked about delayed Shingrix 2nd dose.  The patient not received 2nd dose of Shigrix till the time of reporting still 2 year after 1st dose, which led to incomplete course of vaccination. The reporter asked if series should be continued or restarted. The reporter did not consent to follow-up.
The patient received a pediatric dose of Hep B instead of an adult dose of Hep B.
Severe and persistent fatigue; GI pain; Shooting headaches; Flu-like symptoms including an off and on dry cough, sore throat and overall aches; Flu-like symptoms including an off and on dry cough, sore throat and overall aches; Flu-like symptoms including an off and on dry cough, sore throat and overall aches; Flu-like symptoms including an off and on dry cough, sore throat and overall aches; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021 at 12:15 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included hashimoto's thyroiditis, bartonellosis and unspecified allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medication included levothyroxine sodium (SYNTHROID) 50 mg for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26Feb2021 at 12:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. On 19Mar2021 at 13:30, since the second shot, the patient experienced severe and persistent fatigue, gastrointestinal (GI) pain, sometimes so extreme that she had to lay down for hours, shooting headaches and overall flu-like symptoms including an off and on dry cough, sore throat and overall aches. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events and included treatment as lung x-ray with unknown results, CT scan with unknown results and 1 week of physician bedrest. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe and persistent fatigue, GI pain, shooting headaches and flu-like symptoms including an off and on dry cough, sore throat and overall aches was resolving at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Weakness-Medium, Additional Details: patient felt dizzy and lightheaded and fainted off the chair. never  lost consciousness. recovered after staying in laying down position with knees bent, then had a bottle of water and another drink. walked out after 40 minutes with mom
Woke up at 5am, prepared coffee, and event happened at 5:30 am Felt hot, flushed, sweat pouring down face, weak, dizzy tunnel vision, nausea, fainted and fell hitting my head and left hand on the kitchen counter.  No cuts on my head but my left hand was scraped skin.  I was out for what seemed like 30 seconds after falling. When I came to my husband helped me to the bathroom  because I thought I was going to vomit (I didn't) but I had to hold onto the wall as I experienced jerky movements.  He took me to the hospital.
Pt reports that he noticed skin rash all over his body and some shortness of breath 1 hour after the vaccine administration. his symptoms went away after 1 hour.  He didn't  take any medication at the time of reaction or inform the administrating clinic about the adverse reaction until 3 days afterward.
I experienced chronic hives, leaving me disabled until I could get some Xolair injections. I also experience angioedema, swelling of feet, and pressure hives cause me to be unable to perform any activities some days.
Information has been received from a Licensed Visiting Nurse referring to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 03-MAR-2015 the patient was vaccinated with one dose of VARIVAX (Merck) (lot # K002043, expiration date: 17-03-2015). This vaccine had been previously exposed to both supported excursion and defrosts cycling at various times. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Dr diagnosed her with shingles. Red, rash appearance, bumps/blisters all down left arm, even on top of hand, palm, and between fingers.
After almost two months of vaccine, it started to pain and weakness exactly the area where I got the shot. Sometimes I don't feel that part even if I touch it and sometimes my left arm where I got the shot feels too weak and hurts from inside.
The vial was initially stored in the refrigerator on 29-Sep-2022 and was administered on 1-Nov-2022; No adverse event; 6 doses administered after 30-day use by date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (6 doses administered after 30-day use by date), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 29-Sep-2022 and was administered on 1-Nov-2022) and NO ADVERSE EVENT (No adverse event) in a 7-month-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR9236B) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Nov-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 01-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (6 doses administered after 30-day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 29-Sep-2022 and was administered on 1-Nov-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (6 doses administered after 30-day use by date), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 29-Sep-2022 and was administered on 1-Nov-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (6 doses administered after 30-day use by date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 29-Sep-2022 and was administered on 1-Nov-2022).    No concomitant medications were provided. The vial size was 2.5 ml. The vial was initially stored in the refrigerator on 29-Sep-2022. The vial did not undergo any temperature excursion. No treatment medication was provided.   This case was linked to US-MODERNATX, INC.-MOD-2022-668074, US-MODERNATX, INC.-MOD-2022-668172, US-MODERNATX, INC.-MOD-2022-668208, US-MODERNATX, INC.-MOD-2022-668214, US-MODERNATX, INC.-MOD-2022-668215 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-668074:Same reporter US-MODERNATX, INC.-MOD-2022-668172:Same reporter US-MODERNATX, INC.-MOD-2022-668208:Same reporter US-MODERNATX, INC.-MOD-2022-668214:Same reporter US-MODERNATX, INC.-MOD-2022-668215:Same reporter
Pt is new pt who came to us under immunized.  We are in the process are catching up the patient.  I had written out the order for the vaccines for Pentacel, PCV 13 and Hep B.    However the staff member who pulls the vaccines pulled the Quadracel instead.  No adverse effects are expected.  The quadracel in approved 4 yrs and up.  The patient is 2 and 11 months.  We contacted agency and dose will not need to be repeated.  No problems were noted from the event.
She felt a bit dizzy; Felt weak these lasted a day or two; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (She felt a bit dizzy) and ASTHENIA (Felt weak these lasted a day or two) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007521A and 015A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced DIZZINESS (She felt a bit dizzy) and ASTHENIA (Felt weak these lasted a day or two). On 06-Mar-2021, DIZZINESS (She felt a bit dizzy) and ASTHENIA (Felt weak these lasted a day or two) had resolved.            Concomitant medication information was not reported. Treatment information as not reported. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) is considered as not applicable.   This case was linked to MOD-2021-071043 (Patient Link).
Fever 102, body aches, dizziness, sob, co arm pain local reaction.
Chills, severe body aches and fatigue for the period between 12 and 36 hours post-vaccine, unexpected vaginal bleeding after 48 hours. Continued fatigue and headache after 36 hours
This spontaneous report as received from a pharmacist refers to a male patient of unknown age. On an unknown date the patient was vaccinated with a dose of ZOSTAVAX (lot # not reported) (dose, frequency and route not reported). Concomitant medications were not reported. On an unknown date after receiving ZOSTAVAX the patient developed redness at the injection site. Also on an unspecified date, the patient was diagnosed with chickenpox by his physician. At the time of the report the patient's outcome was unknown. This case is related with MARRS # 1306USA009703. Additional information has been requested.